
CAS 332164-34-8
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
4 produits concernés.
HFI-142
CAS :HFI-142 is a inhibitor to aminopeptidase N; inhibit leukotriene A4 biosynthesis in red blood cells; inhibit dditional aminopeptidases.Formule :C17H16N2O4Couleur et forme :SolidMasse moléculaire :312.32Ethyl 2-amino-7-hydroxy-4-(pyridin-3-yl)-4H-chromene-3-carboxylate
CAS :Degré de pureté :95.0%Masse moléculaire :312.32501220703125Ethyl 2-Amino-7-hydroxy-4-(pyridin-3-yl)-4H-chromene-3-carboxylate
CAS :Produit contrôlé<p>Applications Ethyl 2-Amino-7-hydroxy-4-(pyridin-3-yl)-4H-chromene-3-carboxylate acts as a reagent in the synthesis, structural-activity relationship and the brain uptake of benzopyran inhibitors of insulin regulated aminopeptidase.<br>References Mountford, Simon J., et al.: J. Med. Chem., 57, 1368 (2014)<br></p>Formule :C17H16N2O4Couleur et forme :NeatMasse moléculaire :312.32HFI-142
CAS :<p>HFI-142 is a small molecule that binds to the active site of aminopeptidase N and inhibits its activity. This drug has been shown to inhibit leukotriene A4 biosynthesis in red blood cells, which may be useful for the treatment of cancer. HFI-142 was also found to inhibit the activity of other aminopeptidases, such as aminopeptidase N, as well as other enzymes involved in protein metabolism. The drug showed no mutagenicity in a wide range of assays, including bacterial mutagenicity tests, chromosomal aberration tests with human lymphocytes, and Ames tests.</p>Formule :C17H16N2O4Degré de pureté :Min. 95%Masse moléculaire :312.32 g/mol



